文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

作者信息

Zeng Rong, Spolski Rosanne, Finkelstein Steven E, Oh SangKon, Kovanen Panu E, Hinrichs Christian S, Pise-Masison Cynthia A, Radonovich Michael F, Brady John N, Restifo Nicholas P, Berzofsky Jay A, Leonard Warren J

机构信息

Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

J Exp Med. 2005 Jan 3;201(1):139-48. doi: 10.1084/jem.20041057.


DOI:10.1084/jem.20041057
PMID:15630141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2212766/
Abstract

Interleukin (IL)-21 is the most recently recognized of the cytokines that share the common cytokine receptor gamma chain (gamma(c)), which is mutated in humans with X-linked severe combined immunodeficiency. We now report that IL-21 synergistically acts with IL-15 to potently promote the proliferation of both memory (CD44high) and naive (CD44low) phenotype CD8+ T cells and augment interferon-gamma production in vitro. IL-21 also cooperated, albeit more weakly, with IL-7, but not with IL-2. Correspondingly, the expansion and cytotoxicity of CD8+ T cells were impaired in IL-21R-/- mice. Moreover, in vivo administration of IL-21 in combination with IL-15 boosted antigen-specific CD8+ T cell numbers and resulted in a cooperative effect on tumor regression, with apparent cures of large, established B16 melanomas. Thus, our studies reveal that IL-21 potently regulates CD8+ T cell expansion and effector function, primarily in a synergistic context with IL-15.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/658672f9a202/20041057f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/4b3096004341/20041057f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/3efacce87fc7/20041057f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/7cb5e5ded6aa/20041057f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/905a2ee628c2/20041057f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/de5970d920ea/20041057f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/03ed94b8c597/20041057f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/658672f9a202/20041057f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/4b3096004341/20041057f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/3efacce87fc7/20041057f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/7cb5e5ded6aa/20041057f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/905a2ee628c2/20041057f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/de5970d920ea/20041057f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/03ed94b8c597/20041057f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec4/2212766/658672f9a202/20041057f7.jpg

相似文献

[1]
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

J Exp Med. 2005-1-3

[2]
Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.

Clin Cancer Res. 2011-7-7

[3]
Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2.

Cancer Immunol Immunother. 2009-10

[4]
TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.

Eur J Immunol. 2009-10

[5]
Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells.

Hum Immunol. 2010-10-25

[6]
Ex vivo culture with interleukin (IL)-12 improves CD8(+) T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-gamma but requires perforin.

Cancer Res. 2006-5-1

[7]
Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

J Immunol. 2006-11-1

[8]
Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.

J Immunother. 2010-4

[9]
Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.

J Immunol. 2003-9-1

[10]
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells.

Cancer Immunol Immunother. 2010-1-26

引用本文的文献

[1]
CXCR6 promotes dermal CD8+ T cell survival and transition to long-term tissue residence.

J Immunol. 2025-9-4

[2]
Co-expression of IL-15/IL-15Ra complex enhances NKG2D-CAR T cell-mediated anti-pancreatic cancer immunity by activating the JAK/STAT5 signaling pathway.

Front Immunol. 2025-6-23

[3]
GPC2-targeted CAR T cells engineered with NFAT-inducible membrane-tethered IL-15/IL-21 exhibit enhanced activity against neuroblastoma.

Cancer Immunol Res. 2025-6-26

[4]
Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy.

Front Oncol. 2025-5-21

[5]
A critical role for IL-21/IL-21 receptor signaling in isoproterenol-induced cardiac remodeling.

Sci Rep. 2025-5-30

[6]
The effects of interleukin-21 in the biology of transplant rejection.

Front Immunol. 2025-5-1

[7]
Trifunctional antibody-cytokine fusion protein formats for tumor-targeted combination of IL-15 with IL-7 or IL-21.

Front Immunol. 2025-4-30

[8]
JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid.

Front Immunol. 2025-4-8

[9]
The RNA binding protein CARHSP1 facilitates tumor growth, metastasis and immune escape by enhancing IL-17RA mRNA stabilization in prostate cancer.

Cell Biosci. 2025-3-7

[10]
Presetting CAR-T cells during ex vivo biomanufacturing.

Mol Ther. 2025-4-2

本文引用的文献

[1]
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer.

J Leukoc Biol. 2004-8

[2]
Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

Cell. 2004-4-16

[3]
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.

Proc Natl Acad Sci U S A. 2004-2-17

[4]
In vivo antitumor activity of interleukin 21 mediated by natural killer cells.

Cancer Res. 2003-12-15

[5]
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Nat Immunol. 2003-12

[6]
Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma.

Mol Ther. 2003-10

[7]
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

J Exp Med. 2003-8-18

[8]
IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma.

J Immunol. 2003-7-15

[9]
IL-15 promotes the survival of naive and memory phenotype CD8+ T cells.

J Immunol. 2003-5-15

[10]
Cytokine control of memory T-cell development and survival.

Nat Rev Immunol. 2003-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索